Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Scandi Standard – second quarter presentation

Scandi Standard will publish its report for the second quarter on Thursday, 25th of August 2022 at 07.30 CET. Conference call at 08.30 CETThe Company will host a conference call for the financial community at 08.30 CET the same day.The conference call will be hosted by Jonas Tunestål, CEO and Julia Lagerqvist, CFO. Dial in numbers: United Kingdom: 0800 640 6441United Kingdom (Local): 020 3936 2999Sweden: 0200 123 717Sweden (Local): 010 884 80 16USA: 1 855 9796 654USA (Local): 1 646 664 1960All other locations: +44 20 3936 2999 Participant Access Code: 224604

BioStock: Saniona ready to advance its Kv7 programme

Saniona has announced that the company is on the cusp of advancing its Kv7 programme for epilepsy to lead optimisation, which is the final phase of drug discovery before a clinical candidate is selected. BioStock reached out to CEO Thomas Feldthus to learn more about this new programme.Read the interview with Saniona's CEO Thomas Feldthus at biostock.se: https://www.biostock.se/en/2022/08/saniona-ready-to-advance-its-kv7-programme/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/en/

BioStock Studio: Alligator Bioscience is ready for an exciting news flow

A lot is going on at Alligator Bioscience. CEO Søren Bregenholt visited BioStock’s studio to talk about the news flow expected in the coming months. He commented on updated study plans and is excited about clinical trial read outs, as well as progress in the pipeline and in collaborations. Bregenholt is also looking forward to updating markets about the advanced and structured partnership discussions that Alligator is involved in.Watch the interview with Alligator Bioscience’s CEO Søren Bregenholt at biostock.se: https://www.biostock.se/2022/08/alligator-bioscience-is-ready-for-an-

Company Announcement no. 88, 2022 – Nordea Kredit Realkreditaktieselskab drawings as per 1 October 2022

Nordea Kredit hereby announces drawings data for callable covered mortgage bonds (SDRO) as per 1 October 2022. The figures are published in order to comply with publication requirements in the transparency regulation 2017/1129/EU and the Danish Act on Capital Markets section 24.   Questions can be directed to Torben Jurlander phone +45 55 47 41 99.     Yours faithfully   Nordea Kredit Realkreditaktieselskab

Funding decisions in Metsä Group's nature program

Metsä Group press release 19 August 2022Metsä Group has made funding decisions in the most recent application process of its nature program. A diverse set of cooperation projects to safeguard the diversity of Finnish nature was chosen to be funded. Experts from key stakeholders in the natural resources sector participated in the project evaluation. In the autumn of 2021, Metsä Group launched a ten-year programme to support regionally effective development projects that support biodiversity and the state of waters. The projects may relate to bird waters and wetlands, watercourse routes,

Readly partners with Lidl to offer Lidl Plus grocery shoppers unlimited digital magazines and newspapers

                                                         Readly, Europe’s leading digital magazine and newspaper subscription app, has partnered with Lidl to offer customers a free two month subscription to its portfolio of titles. The partnership is the latest in a series of high profile brand collaborations for Readly and a strategic move to bring its broad portfolio of titles to grocery customers. Famous for providing customers with high quality products at the lowest possible prices, the partnership with Lidl involves Readly giving Lidl Plus rewards app customers a

Eitrium acquires Eliasson Plast AB, a manufacturer of Plastic Goods

Eitrium has acquired all shares in Eliasson Plast AB, a Swedish manufacturer of plastic products within packaging and plant growing industries. The sellers, the Eliasson-family, will continue to operate Eliasson Plast AB to ensure the continuation of its way of doing business.The Borås-based business has remained in operation since 1976. The focus has historically been on packaging products such as lids, plugs and ends for cardboard sleeves. Today, these products are still an important product group, but have since been complemented with their own proprietary products in the plant growing

Skanska conducts preparatory works for a new emergency hospital in Växjö, Sweden, for about SEK 1.2 billion

Skanska and the Kronoberg Region have signed an agreement on phase one of the work on Växjö's new emergency hospital. Phase one involves pre-construction work in strategic collaboration for the hospital. The contract is worth about SEK 1.2 billion, which will be included in the order bookings for Sweden in the third quarter of 2022.Last spring, Skanska and the Kronoberg Region signed an agreement on a feasibility study for the new emergency hospital that will replace the existing hospital in Växjö. In total, there are approximately 135,000 square meters of new construction to be carried out

DanCann Pharma A/S: Standardized medicinal cannabis products are essential for the medical profession – and ultimately for the patients

COPENHAGEN, Denmark, 19 August 2022 - DanCann Pharma A/S (SS: DANCAN) (“DanCann Pharma” or the “Company”) comment on the importance of standardization of medicinal cannabis productsThe Danish biopharmaceutical manufacturer DanCann Pharma has established the high-tech production facility, Biotech Pharm1 (“BP1"), in order to be able to produce standardized medicinal cannabis products. The facility is built based on best practice from the pharmaceutical industry in combination with advanced environmentally controlled agricultural technology and vertical agriculture. BP1 is designed to

Hexagon Digital Wave signs testing service agreement with NG Advantage Ltd – using Modal Acoustic Emission technology to requalify Type-4 cylinders

19 August 2022: Hexagon Digital Wave has signed a strategic testing service agreement with NG Advantage LLC, a leading provider of turnkey virtual pipeline solutions in the United States. Hexagon Digital Wave will perform in situ Modal Acoustic Emission (MAE) requalification of Type-4 cylinders used for transportation of compressed natural (renewable) gas (CNG/RNG). MAE enables the requalification of Type-4 cylinders without removal from the trailer, resulting in reduced downtime and operator overhead, all while providing the most effective assessment of composite structural integrity

The development in Skönvik has commenced. SBB has signed a 25-year municipal lease for a preschool in the Municipality of Säter

Samhällsbyggnadsbolaget i Norden AB ("SBB") has signed a 25-year lease with the Municipality of Säter regarding a new preschool in Skönvik for 120 children. This is the starting point for community development in Skönvik with housing and community services, the preschool is expected to be completed in 2024. SBB is a long-term partner to the public sector by owning, managing and developing community service properties in the Nordics as well as rent regulated residentials in Sweden. With our own local property management organisation and with extensive experience in developing learning

BULLETIN FROM EXTRAORDINARY GENERAL MEETING IN GAPWAVES AB (publ)

Extraordinary General Meeting on August 19, 2022, in Gapwaves AB (publ), org. No. 556840-2829An Extraordinary General Meeting of Gapwaves AB (publ) was held today by postal vote, without the possibility of physical participation, with the support of temporary legal rules. The following main items were resolved upon. Resolution regarding determination of the number of directors The Extraordinary General Meeting resolved, in accordance with the nomination committee´s proposal, that the number of directors for the period until the next Annual General Meeting shall be five and the number

Notification of managers’ and closely related parties’ transactions with Dampskibsselskabet NORDEN A/S’ shares in connection with share buy-back program

ANNOUNCEMENT NO. 159 - 19 AUGUST 2022  In connection with the announced share buy-back program in NORDEN, A/S Motortramp sells shares pro rata and the market is to be informed accordingly – see the attached file and announcement no. 158/22. A/S Motortramp participates in NORDEN’s share buy-back program by selling shares pro rata in order to maintain the current ownership of just under 32% of the shares in NORDEN.     Kind regards, Dampskibsselskabet NORDEN A/S   Martin Badsted CFO     For further information: Thomas France, Investor Communications

Calmark receives order from India

Calmark Sweden AB (publ) announces today that an order for 50 instruments and 2,000 test cassettes relating to the Calmark Neo-Bilirubin product has been received from the Company's distributor in India, r2 Diagnostics. The registration process in India for the products is ongoing and is anticipated to be completed shortly.Today's order comprises 50 instruments with associated test cassettes to be dispatched to end customers in selected children’s hospitals in India according to a release plan. The order will be delivered as soon as the registration process is completed.  “I am very

Lumito – Associated Member of PathLAKE and part of the Consortium's highly valuable network

Lumito's application for Associate Membership of the PathLAKE Consortium has been approved. The PathLAKE Consortium is a network of leading NHS Trusts and UK universities who, in collaboration with industrial partners, are at the forefront of innovation in digital pathology. The Consortium's work includes AI-driven diagnostics to increase the efficiency and effectiveness of pathology reporting and improve patient outcomes through advanced diagnostics and patient selection for personalized medicine.“I am proud of Lumito being an Associated Member of PathLAKE, which I see as a recognition

PharmNovo starts clinical phase I studies of a drug candidate for neuropathic pain

PharmNovo AB, a Swedish pharmaceutical company developing drugs for neuropathic pain, so-called nerve pain, today announces that phase I studies of the drug candidate PN6047 have been initiated.The drug candidate PN6047 from PharmNovo is an entirely new drug. The substance is a selective delta opioid, a so-called DORA (delta opioid receptor agonist), which, in animal models, effectively relieves nerve pain. It does so without causing the unwanted side effects of conventional opioid drugs on the market today. During the summer, the application to start clinical studies of PN6047 was

Scandion Oncology receives approvals for next parts of the CORIST trial

The development of SCO-101 will continue as planned with expansion of the CORIST trial expected to commence during the third quarter of 2022.Scandion Oncology (Scandion), a biotech company developing first-in-class medicines aimed at treating cancer which is resistant to current treatment options, has now received approvals from authorities and ethical committees in Denmark and Germany for the next parts of the ongoing CORIST phase II-trial. The trial studies Scandion’s lead compound SCO-101 as a combination treatment in patients with metastatic colorectal cancer (mCRC). Thus, the

Interim Report 220101-220630

Press Release 19 August, 2022Summery of Interim Report First to Second Quarter 2022(2022-01-01 – 2022-06-30) • Operating income amounted to 903 789 (528 702) SEK. • Earnings after financial items amounted to - 5 911 082 (-4 008 690) SEK. • Earnings per share * amounted to SEK -0.18 (-0.18). • Equity / assets ratio was 93% (83%). Second Quarter 2022(2022-04-01 – 2022-06-30) • Operating income amounted to 685 380 (527 625) SEK. • Earnings after financial items amounted to - 3 209 011 (-2 229 708) SEK. • Earnings per share * amounted to SEK – 0.10 (-0.10). *

Sanolium AB interim report, April – June 2022

Revenue in the second quarter amounted to 219.5 (195.8) MSEK, representing an increase of 12.1%. Support and maintenance fees constitute the largest share of the revenue. License revenue and Professional Services revenue are attributable to the development of the existing product as well as the Sussa project. Adjusted EBITDA in the second quarter amounted to 61.0 (46.1) MSEK resulting in an adjusted EBITDA margin of 27.8 (23.5) %. Employee related expenses amounted to 123.1 (117.8) MSEK, representing an increase of 4.5 %. The number of full time equivalents (FTE) was 702 at the end of

Jan Gurander to step down as Volvo Group Deputy CEO

Jan Gurander will step down as Volvo Group Deputy CEO as of December 31[st], 2022. His other managerial assignments within the Group will gradually be distributed to other members of the Volvo Group Executive Board. After the turn of the year, Jan Gurander will stand available to President and CEO Martin Lundstedt´s disposal.Jan Gurander has a long and successful career within the Volvo Group, starting as Volvo Group Chief Financial Officer in 2014. He held the role of acting President and CEO for parts of 2015 and was appointed Deputy CEO in 2016. Prior to his career in the Volvo Group,

MEDIVIR AB – INTERIM REPORT JANUARY – JUNE 2022

The clinical development of fostrox remains our focus  April – June Financial summary for the quarter · Net turnover amounted to SEK 0.5 (0.9) million. · The loss before interest, tax, depreciation and amortization (EBITDA) amounted to SEK -21.5 (-17.1) million. Basic and diluted earnings per share amounted to SEK -0.42 (-0.31) and SEK -0.42 (-0.31) respectively. · Cash flow from operating activities amounted to SEK -17.6 (-21.9) million. · Cash and cash equivalents at the end of the period amounted to SEK 162.8 (247.8) million.   Significant events during the

HODL SPAC Europe AB: Half-year report 2022

HODL SPAC Europe AB (publ) hereby publishes the interim report for the period January – June 2022.  The interim report is available as an attached document and on the company's website (www.hodlspac.se). Below is a summary of the report.Half-year 2022[1] ●        Earnings per share amounted to SEK -0.05 (--). ●        Profit after tax amounted to TSEK -428,5  (--). ●        Cash and cash equivalents at 30 June 2022 amounted to TSEK 29 173,8  (--). Second quarter 2022 ●        Earnings per share amounted to SEK -0.02 (--). ●        Profit after tax amounted to TSEK -428,5  (

Heliospectra (publ) Publish the Half-Year Report for January-June 2022

(GOTHENBURG, Sweden, Aug 19, 2022, at 08:30 CET)– Heliospectra AB (publ), a leader in intelligent lighting technology for greenhouse and controlled plant growth environments, presents its Half-Year Report for January-June 2022.Full report is enclosed to this press release and is also uploaded at https://www.heliospectra.com/investor-relations/reports-documents-archive. SUMMARY OF REPORT SALES AND FINANCIAL PERFORMANCE APRIL-JUNE · Order intake during the period April - June amounted to SEK 5,346 (-61,492) thousand. · Net sales during the period April - June amounted to SEK 3,

Second quarter report Q2-2022 – green light for the pivotal trial 0205

Cessatech A/S (“Cessatech” or the “Company”) today releases its results for the period 1 April – 30 June 2022. The second quarter report is available as an attached document to this press release and on www.cessatech.com under Investor/Filings & Reports. The Company is progressing with planned activities: Recruitment of trial 0206 was completed (a trial to investigate the pharmacokinetics in children aged 1-17 undergoing elective surgical procedures) and finally regulatory approval was received and thereby a green light to initiate recruitment of the pivotal trial 0205 with CT001, a

There are no items matching the current filter
There are no more items matching the current filter
Back to top